219 related articles for article (PubMed ID: 10414593)
21. Determination of kappa and lambda light chains in serum immunoglobulins G, A and M.
Haraldsson A; Kock-Jansen MJ; Jaminon M; van Eck-Arts PB; de Boo T; Weemaes CM; Bakkeren JA
Ann Clin Biochem; 1991 Sep; 28 ( Pt 5)():461-6. PubMed ID: 1958048
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal gammopathy related to Sjögren syndrome: a key marker of disease prognosis and outcomes.
Brito-Zerón P; Retamozo S; Gandía M; Akasbi M; Pérez-De-Lis M; Diaz-Lagares C; Bosch X; Bové A; Pérez-Alvarez R; Soto-Cárdenas MJ; Sisó A; Ramos-Casals M
J Autoimmun; 2012 Aug; 39(1-2):43-8. PubMed ID: 22297146
[TBL] [Abstract][Full Text] [Related]
23. [Serum levels of IgG, IgA, IgM, transferrin and haptoglobin. III. Results obtained with monoclonal immunoglobulins].
Pontet F; Later R; Manceaux JC; Pressac M; Boigné JM
Ann Biol Clin (Paris); 1995; 53(5):283-91. PubMed ID: 7574116
[TBL] [Abstract][Full Text] [Related]
24. IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy.
Mehndiratta MM; Sen K; Tatke M; Bajaj BK
J Neurol Sci; 2004 Jun; 221(1-2):99-104. PubMed ID: 15178222
[TBL] [Abstract][Full Text] [Related]
25. Oligoclonal bands staining for IgG, IgA, IgM, and kappa and lambda light chains in cerebrospinal fluid of patients with multiple sclerosis.
Araga S; Irie H; Takahashi K
Jpn J Psychiatry Neurol; 1988 Dec; 42(4):805-9. PubMed ID: 3150478
[TBL] [Abstract][Full Text] [Related]
26. [Three M-components (IgG kappa, IgA kappa, IgM kappa) in a patient with non-Hodgkin's lymphoma].
Fujita H; Matsuzaki M; Murata T; Noguchi T; Hashimoto Y; Tanabe J; Mohri H; Ookubo T; Watanabe S; Hirabayashi Y
Rinsho Ketsueki; 1992 Mar; 33(3):384-90. PubMed ID: 1578644
[TBL] [Abstract][Full Text] [Related]
27. Neuropathy associated with monoclonal gammopathies of undetermined significance.
Gosselin S; Kyle RA; Dyck PJ
Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
[TBL] [Abstract][Full Text] [Related]
28. Change in relative mobility of M protein following neuraminidase treatment in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
Kurihara Y; Iijima S; Fukushima K; Hosaka T; Shiba K
J Clin Lab Anal; 2004; 18(3):182-6. PubMed ID: 15103683
[TBL] [Abstract][Full Text] [Related]
29. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS.
Suarez GA; Kelly JJ
Neurology; 1993 Jul; 43(7):1304-8. PubMed ID: 8327128
[TBL] [Abstract][Full Text] [Related]
30. Immunoglobulin profile in HIV-1 infected children in Dar es Salaam.
Lyamuya EF; Matee MI; Kasubi M; Scheutz F
East Afr Med J; 1999 Jul; 76(7):370-5. PubMed ID: 10520363
[TBL] [Abstract][Full Text] [Related]
31. Serum immunoglobulins IgG, IgA and IgM in patients with oral lichen ruber.
Biocina-Lukenda D; Cekić-Arambasin A; Markeljević J; Buković D
Coll Antropol; 2008 Mar; 32(1):161-3. PubMed ID: 18496909
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of 128 cases of multiple myeloma and 31 cases of monoclonal gammapathies of undetermined significance].
Zhu JZ; Kuo TT; Wang HR
Zhonghua Nei Ke Za Zhi; 1989 Aug; 28(8):463-5, 508. PubMed ID: 2598728
[TBL] [Abstract][Full Text] [Related]
33. Affinity immunoblotting: rapid and sensitive detection of oligoclonal IgG, IgA and IgM in unconcentrated CSF by agarose isoelectric focusing.
Kaiser R
J Neurol Sci; 1991 Jun; 103(2):216-25. PubMed ID: 1880540
[TBL] [Abstract][Full Text] [Related]
34. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size.
Fisher MA; Wilson JR
Neurol Clin Neurophysiol; 2002; 2002(3):2-7. PubMed ID: 12028821
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
Martín-Jiménez P; García-Sanz R; Balanzategui A; Alcoceba M; Ocio E; Sanchez ML; González M; San Miguel J
Haematologica; 2007 May; 92(5):635-42. PubMed ID: 17488687
[TBL] [Abstract][Full Text] [Related]
36. Selection of patients with monoclonal gammopathy of undetermined significance is mandatory for a reliable use of interleukin-6 and other nonspecific multiple myeloma serum markers.
Greco C; Ameglio F; Alvino S; Cianciulli AM; Giovannelli M; Mattei F; Vitelli G; Venturo I; Lopez M; Gandolfo GM
Acta Haematol; 1994; 92(1):1-7. PubMed ID: 7985475
[TBL] [Abstract][Full Text] [Related]
37. Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios.
Bradwell AR; Harding SJ; Fourrier NJ; Wallis GL; Drayson MT; Carr-Smith HD; Mead GP
Clin Chem; 2009 Sep; 55(9):1646-55. PubMed ID: 19617289
[TBL] [Abstract][Full Text] [Related]
38. [Abnormal laboratory data due to interaction between immunoglobulins and other serum proteins].
Fujita K; Kameko F; Hidaka H
Rinsho Byori; 2005 Apr; 53(4):340-4. PubMed ID: 15915773
[TBL] [Abstract][Full Text] [Related]
39. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
[TBL] [Abstract][Full Text] [Related]
40. Two-dimensional electrophoretic analysis of immunoglobulin patterns in monoclonal gammopathies.
Goldfarb MF
Electrophoresis; 1992 Jul; 13(7):440-4. PubMed ID: 1425557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
